Veselības aprūpes speciālistu informētība par COVID-19 vakcīnu izraisīto trombozes ar trombocitopēniju sindromu
No Thumbnail Available
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rīgas Stradiņa universitāte
Rīga Stradiņš University
Rīga Stradiņš University
Abstract
Šī pētījuma nosaukums ir “Veselības aprūpes speciālistu informētība par COVID-19 vakcīnu izraisīto trombozes ar trombocitopēniju sindromu”.
COVID-19 ir pandēmija, kuru izraisīja SARS-CoV-2 vīruss. Vakcinācija pret COVID-19 ir primārais veids, kā novērst slimības izplatīšanos. Pēcreģistrācijas periodā tika ziņots par ļoti retiem trombembolijas gadījumiem ar zemu trombocītu skaitu (TTS) vektoru vakcīnām. 2021. gadā EZA secināja par cēloņsakarību un publicēja ieteikumus uzraudzīt cilvēkus pēc Vaxzevria un Jcovden vakcīnas saņemšanas.
Šī pētījuma mērķis ir aprakstīt veselības aprūpes speciālistu informētību un zināšanas par TTS risku, kas saistīts ar pret SARS-CoV-2 adenovīrusa vektora vakcīnām un tā pārvaldību.
Analizējot datus, kas tika iegūti no veselības aprūpes speciālistiem, kuri bija iesaistīti vakcinācijā pret COVID-19, secināts, ka lielākā daļa zina par TTS esamību un zina tā simptomus. Puse aptaujāto zina, ka TTS attīstības iespējamība ir ļoti zema. Izmaiņu ieviešana Vaxzevria un Jcovden vakcinācijas ieteikumos un vadlīnijās pozitīvi ietekmēja veselības aprūpes speciālistu uzvedību.
The title of this research paper is “Awareness of the COVID-19 vaccine induced thrombosis with thrombocytopenia syndrome among the healthcare professionals”. COVID-19 is a pandemic caused by the SARS-CoV-2 virus. Vaccination against COVID-19 is the primary way to prevent the spread of the disease. In the post authorization period very rare cases of thromboembolic events with low platelet counts (TTS) were reported for vector vaccines. In 2021 EZA concluded on causation and issued recommendations to monitor people after receiving Vaxzevria and Jcovden. The aim of this study is to describe the level of heathcare professional awareness and knowledge of the risk of TTS associated with SARS-CoV-2 adenovirus vector vaccines and it’s management. Analysis of the data obtained from healthcare professionals that were involved in vaccination against COVID-19 concluded that majority is aware of the existence of TTS and know its symptoms. Half of the respondents know that the probability of developing TTS is very low. Implementation of changes to vaccination recommendations and guidelines for Vaxzevria and Jcovden had a positive impact on behavior of healthcare professionals.
The title of this research paper is “Awareness of the COVID-19 vaccine induced thrombosis with thrombocytopenia syndrome among the healthcare professionals”. COVID-19 is a pandemic caused by the SARS-CoV-2 virus. Vaccination against COVID-19 is the primary way to prevent the spread of the disease. In the post authorization period very rare cases of thromboembolic events with low platelet counts (TTS) were reported for vector vaccines. In 2021 EZA concluded on causation and issued recommendations to monitor people after receiving Vaxzevria and Jcovden. The aim of this study is to describe the level of heathcare professional awareness and knowledge of the risk of TTS associated with SARS-CoV-2 adenovirus vector vaccines and it’s management. Analysis of the data obtained from healthcare professionals that were involved in vaccination against COVID-19 concluded that majority is aware of the existence of TTS and know its symptoms. Half of the respondents know that the probability of developing TTS is very low. Implementation of changes to vaccination recommendations and guidelines for Vaxzevria and Jcovden had a positive impact on behavior of healthcare professionals.
Description
Farmācija
Pharmacy
Veselības aprūpe
Health Care
Pharmacy
Veselības aprūpe
Health Care
Keywords
COVID-19; vakcinācija; veselības aprūpes speciālisti; trombozes ar trombocitopēniju sindroms (TTS), COVID-19; vaccination; healthcare professionals (HCPs); thrombosis with thrombocytopenia syndrome (TTS)